Potential contribution of fungal infection and colonization to the development of allergy

Medical Mycology

Volumn 47, Issue 5, 2009, Pages 445-456

  Goldman, David L ^a   Huffnagle, Gary B ^b  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF MICHIGAN   (United States)

Author keywords

Allergy; Asthma; Candida; Fungi; Infection

Indexed keywords

ALLERGEN; ANTIGEN; CHITIN; CHITINASE; FUNGAL ENZYME; FUNGAL PROTEIN; GLUCURONOXYLOMANNAN; IMMUNOGLOBULIN E; INTERLEUKIN 10; INTERLEUKIN 13; INTERLEUKIN 4; INTERLEUKIN 6; INTERLEUKIN 8; LEUKOCYTE ELASTASE; MAJOR BASIC PROTEIN; PROSTAGLANDIN D2; PROSTAGLANDIN E2; PROTEINASE;

ALLERGIC ASTHMA; ALLERGIC FUNGAL SINUSITIS; ASPERGILLOMA; ASPERGILLUS FUMIGATUS; ATOPIC DERMATITIS; BACTERIAL FLORA; CANDIDA ALBICANS; CLINICAL FEATURE; CROHN DISEASE; CRYPTOCOCCOSIS; CRYPTOCOCCUS NEOFORMANS; CURVULARIA; CYTOKINE PRODUCTION; DERMATOMYCOSIS; ENVIRONMENTAL EXPOSURE; FUNGAL COLONIZATION; FUNGUS IMMUNITY; HOST PATHOGEN INTERACTION; HUMAN; IMMUNE RESPONSE; INTESTINE FLORA; MALASSEZIA; MUCOSAL IMMUNITY; NONHUMAN; PATHOGENESIS; REGULATORY T LYMPHOCYTE; REVIEW; SINUSITIS; TH2 CELL;

CANDIDA; HOST-PATHOGEN INTERACTIONS; HUMANS; HYPERSENSITIVITY; MYCOSES; RESPIRATORY HYPERSENSITIVITY;

CANDIDA; FUNGI;

EID: 70749118179     PISSN: 13693786     EISSN: 14602709     Source Type: Journal    
DOI: 10.1080/13693780802641904     Document Type: Review

References (173)

1. Denning DW, O'Driscoll BR, Hogaboam CM, Bowyer P, Niven RM. The link between fungi and severe asthma: a summary of the evidence. Eur Respir J 2006; 27: 615-626.
2. O'Hollaren MT, Yunginger JW, Offord KP, Somers MJ, O'Connell EJ, Ballard DJ, et al. Exposure to an aeroallergen as a possible precipitating factor in respiratory arrest in young patients with asthma. N Engl J Med 1991; 324: 359-363.
3. Targonski PV, Persky VW, Ramekrishnan V. Effect of environmental molds on risk of death from asthma during the pollen season. J Allergy Clin Immunol 1995; 95: 955-961.
4. Zureik M, Neukirch C, Leynaert B, et al. Sensitisation to airborne moulds and severity of asthma: cross sectional study from European Community respiratory health survey. BMJ 2002; 325: 411-414.
5. Black PN, Udy AA, Brodie SM. Sensitivity to fungal allergens is a risk factor for life-threatening asthma. Allergy 2000; 55: 501-504.
6. Sabato AR, Martin AJ, Marmion BP, Kok TW, Cooper DM. Mycoplasma pneumoniae: acute illness, antibiotics, and subsequent pulmonary function. Arch Dis Child 1984; 59: 1034-1037.
7. Hahn DL, Dodge RW, Golubjatnikov R. Association of Chlamydia pneumoniae (strain TWAR) infection with wheezing, asthmatic bronchitis, and adult-onset asthma. JAMA 1991; 266: 225-230.
8. Welliver RC. RSV and chronic asthma. Lancet 1995; 346: 789-790.
9. Hinkson, Moon AJ, Plummer NS. Broncho-pulmonary aspergillosis; a review and a report of eight new cases. Thorax 1952; 7: 317-333.
10. Eaton T, Garrett J, Milne D, Frankel A, Wells AU. Allergic bronchopulmonary aspergillosis in the asthma clinic. A prospective evaluation of CT in the diagnostic algorithm. Chest 2000; 118: 66-72.
11. Krasnick J, Greenberger PA, Roberts M, Patterson R. Allergic bronchopulmonary aspergillosis: serologic update for 1995. J Clin Lab Immunol 1995; 46: 137-142
12. Schwartz HJ, Greenberger PA. The prevalence of allergic bronchopulmonary aspergillosis in patients with asthma, determined by serologic and radiologic criteria in patients at risk. J Lab Clin Med 1991; 117: 138-142.
13. Laufer P, Fink JN, Bruns WT, Unger GF, Kalbfleisch JH, Greenberger PA, et al. Allergic bronchopulmonary aspergillosis in cystic fibrosis. J Allergy Clin Immunol 1984; 73: 44-48.
14. Zeaske R, Bruns WT, Fink JN, Greenberger PA, Colby H, Liotta JL, et al. Immune responses to Aspergillus in cystic fibrosis. J Allergy Clin Immunol 1988; 82: 73-77.
15. Becker JW, Burke W, McDonald G, et al. Prevalence of allergic bronchopulmonary aspergillosis and atopy in adult patients with cystic fibrosis. Chest 1996; 109: 1536-1540.
16. Hoshino H, Tagaki S, Kon H, Shibusa T, Takabatake H, Fujita A, et al. Allergic bronchopulmonary aspergillosis due to Aspergillus niger without bronchial asthma. Respiration 1999; 66: 369-372.
17. Laham MN, Allen RC, Greene JC. Allergic bronchopulmonary aspergillosis (ABPA) caused by Aspergillus terreus: specific lymphocyte sensitization and antigen-directed serum opsonic activity. Ann Allergy 1981; 46: 74-80.
18. Akiyama K, Takizawa H, Suzuki M, et al. Allergic bronchopulmonary aspergillosis due to Aspergillus oryzae. Chest 1987; 91: 285-286.
19. Sandhu RS, Mehta SK, Khan ZU, Singh MM. Role of Aspergillus and Candida species in allergic bronchopulmonary mycoses. A comparative study. Scand J Respir Dis 1979; 60: 235-242.
20. Lake FR, Tribe AE, McAleer R, Froudist J, Thompson PJ. Mixed allergic bronchopulmonary fungal disease due to Pseudallescheria boydii and Aspergillus. Thorax 1990; 45: 489-491.
21. Wark PA, Gibson PG, Wilson AJ. Azoles for allergic bronchopulmonary aspergillosis associated with asthma. Cochrane Database Syst Rev 2004; CD001108.
22. Stevens DA, Schwartz HJ, Lee JY, Moskovitz BL, Jerome DC, Catanzaro A, et al. A randomized trial of itraconazole in allergic bronchopulmonary aspergillosis. N Engl J Med 2000; 342: 756-762.
23. Moss RB. Pathophysiology and immunology of allergic bronchopulmonary aspergillosis. Med Mycol 2005; 43 (Suppl. 1): S203-S206.
24. Stevens DA, Moss RB, Kurup VP, Knutsen AP, Greenberger P, Judson MA, et al. Allergic bronchopulmonary aspergillosis in cystic fibrosis -state of the art: Cystic Fibrosis Foundation Consensus Conference. Clin Infect Dis 2003; 37 (Suppl. 3): S225-S264.
25. Braedel S, Radsak M, Einsele H, Latge JP, Michan A, Loeffler J, et al. Aspergillus fumigatus antigens activate innate immune cells via toll-like receptors 2 and 4. Br J Haematol 2004; 125: 392-399.
26. Mambula SS, Sau K, Henneke P, Golenbock DT, Levitz SM. Toll-like receptor (TLR) signaling in response to Aspergillus fumigatus. J Biol Chem 2002; 277: 39320-43926
27. Lamhamedi-Cherradi SE, Martin RE, Ito T, Kheradmand F, Corry DB, Liu YJ, et al. Fungal proteases induce Th2 polarization through limited dendritic cell maturation and reduced production of IL-12. J Immunol 2008; 180: 6000-6009.
28. Geha RS. Circulating immune complexes and activation of the complement sequence in acute allergic bronchopulmonary aspergillosis. J Allergy Clin Immunol 1977; 60: 357-359.
29. Skov M, Poulsen LK, Koch C. Increased antigen-specific Th-2 response in allergic bronchopulmonary aspergillosis (ABPA) in patients with cystic fibrosis. Pediatr Pulmonol 1999; 27: 74-79. (Pubitemid 29104444)
30. Knutsen AP,Mueller KR, Levine AD, et al. Asp f I CD4-TH2- like T-cell lines in allergic bronchopulmonary aspergillosis. J Allergy Clin Immunol 1994; 94: 215-221.
31. Chauhan B, Knutsen A, Hutcheson PS, Slavin RG, Bellone CJ. T cell subsets, epitope mapping, and HLA-restriction in patients with allergic bronchopulmonary aspergillosis. J Clin Invest 1996; 97: 2324-2331.
32. Amitani R, Murayama T, Nawada R, Lee WJ, Niimi A, Suzuki K, et al. Aspergillus culture filtrates and sputum sols from patients with pulmonary aspergillosis cause damage to human respiratory ciliated epithelium in vitro. Eur Respir J 1995; 8: 1681-1687.
33. Amitani R, Taylor G, Elezis EN, Llewellyn-Jones C, Mitchell J, Kuze F, et al. Purification and characterization of factors produced by Aspergillus fumigatus which affect human ciliated respiratory epithelium. Infect Immun 1995; 63: 3266-3271.
34. Botterel F, Cordonnier C, Barbier V, Wingerstmann L, Liance M, Coste A, et al. Aspergillus fumigatus causes in vitro electrophysiological and morphological modifications in human nasal epithelial cells. Histol Histopathol 2002; 17: 1095-1101.
35. Kauffman HF, Tomee JF, Van De Riet MA, Timmerman AJ, Borger P. Protease-dependent activation of epithelial cells by fungal allergens leads to morphologic changes and cytokine production. J Allergy Clin Immunol 2000; 105: 1185-1193.
36. Tomee JF, Wierenga AT, Hiemstra PS, Kauffman HK. Proteases from Aspergillus fumigatus induce release of proinflammatory cytokines and cell detachment in airway epithelial cell lines. J Infect Dis 1997; 176: 300-303.
37. Park SJ, Wiekowski MT, Lira SA, Mehrad B. Neutrophils regulate airway responses in a model of fungal allergic airways disease. J Immunol 2006; 176: 2538-2545.
38. Gibson PG, Wark PA, Simpson JL, Meldrum C, Meldrum S, Saltos N, et al. Induced sputum IL-8 gene expression, neutrophil influx and MMP-9 in allergic bronchopulmonary aspergillosis. Eur Respir J 2003; 21: 582-588.
39. Wark PA, Saltos N, Simpson J, et al. Induced sputum eosinophils and neutrophils and bronchiectasis severity in allergic bronchopulmonary aspergillosis. Eur Respir J 2000; 16: 1095-1101.
40. Robinson BW, Venaille TJ,Mendis AH, McAleer R. Allergens as proteases: an Aspergillus fumigatus proteinase directly induces human epithelial cell detachment. J Allergy Clin Immunol 1990; 86: 726-731.
41. Tomee JF, Van Der Werf TS, Latge JP, et al. Serologic monitoring of disease and treatment in a patient with pulmonary aspergilloma. Am J Respir Crit Care Med 1995; 151: 199-204.
42. Gibson PG. Allergic bronchopulmonary aspergillosis. Semin Respir Crit Care Med 2006; 27: 185-191.
43. Bent JP, III, Kuhn FA. Diagnosis of allergic fungal sinusitis. Otolaryngol Head Neck Surg 1994; 111: 580-588.
44. Houser SM, Corey JP. Allergic fungal rhinosinusitis: pathophysiology, epidemiology, and diagnosis. Otolaryngol Clin North Am 2000; 33: 399-409.
45. Stewart AE, Hunsaker DH. Fungus-specific IgG and IgE in allergic fungal rhinosinusitis. Otolaryngol Head Neck Surg 2002; 127: 324-332.
46. Manning SC, Holman M. Further evidence for allergic pathophysiology in allergic fungal sinusitis. Laryngoscope 1998; 108: 1485-1496.
47. Collins M, Nair S, Smith W, et al. Role of local immunoglobulin E production in the pathophysiology of noninvasive fungal sinusitis. Laryngoscope 2004; 114: 1242-1246.
48. Khan DA, Cody DT, George TJ, Gleich GJ, Leiferman KM. Allergic fungal sinusitis: an immunohistologic analysis. J Allergy Clin Immunol 2000; 106: 1096-1101.
49. Schubert MS. Allergic fungal sinusitis: pathogenesis and management strategies. Drugs 2004; 64: 363-374.
50. Chakrabarti A, Das A, Panda NK. Controversies surrounding the categorization of fungal sinusitis. Med Mycol 2008; 46: 1-10.
51. McCann WA, Cromie M, Chandler F, Ford J, Dolen WK. Sensitization to recombinant Aspergillus fumigatus allergens in allergic fungal sinusitis. Ann Allergy Asthma Immunol 2002; 89: 203-208.
52. Schubert MS, Goetz DW. Evaluation and treatment of allergic fungal sinusitis. I. Demographics and diagnosis. J Allergy Clin Immunol 1998; 102: 387-394.
53. De Shazo RD, Swain RE. Diagnostic criteria for allergic fungal sinusitis. J Allergy Clin Immunol 1995; 96: 24-35.
54. Faergemann J. Atopic dermatitis and fungi. Clin Microbiol Rev 2002; 15: 545-563.
55. Woodfolk JA. Allergy and dermatophytes. Clin Microbiol Rev 2005; 18: 30-43.
56. Platts-Mills TA, Fiocco GP, Hayden ML, et al. Serum IgE antibodies to Trichophyton in patients with urticaria, angioedema, asthma, and rhinitis: development of a radioallergosorbent test. J Allergy Clin Immunol 1987; 79: 40-45.
57. Weary PE, Guerrant JL. Chronic urticaria in association with dermatophytosis. Response to the administration of griseofulvin. Arch Dermatol 1967; 95: 400-401.
58. Waersted A, Hjorth N. Pityrosporum orbiculare - a pathogenic factor in atopic dermatitis of the face, scalp and neck? Acta Derm Venereol 1985; 114 (Suppl.): 146-148.
59. Kim TY, Jang IG, Park YM, Kim HO, Kim CW. Head and neck dermatitis: the role of Malassezia furfur, topical steroid use and environmental factors in its causation. Clin Exp Dermatol 1999; 24: 226-231.
60. Takahata Y, Sugita T, Kato H, et al. Cutaneous Malassezia flora in atopic dermatitis differs between adults and children. Br J Dermatol 2007; 157: 1178-1182.
61. Kato H, Sugita T, Ishibashi Y, Nishikawa A. Detection and quantification of specific IgE antibodies against eight Malassezia species in sera of patients with atopic dermatitis by using an enzyme-linked immunosorbent assay. Microbiol Immunol 2006; 50: 851-856.
62. Wessels MW, Doekes G, Van Ieperen-Van Kijk AG, Koers WJ, Young E. IgE antibodies to Pityrosporum ovale in atopic dermatitis. B J Dermatol 1991; 125: 227-232.
63. Watanabe S, Kano R, Sato H, Nakamura Y, Hasegawa A. The effects of Malassezia yeasts on cytokine production by human keratinocytes. J Invest Dermatol 2001; 116: 769-773.
64. Ishibashi Y, Sugita T, Nishikawa A. Cytokine secretion profile of human keratinocytes exposed to Malassezia yeasts. FEM Immun Med Microbiol 2006; 48: 400-409.
65. Buentke E, Heffler LC, Wallin RP, et al. The allergenic yeast Malassezia furfur induces maturation of human dendritic cells. Clin Exp Allergy 2001; 31: 1583-1593.
66. Mayser P, Kupfer J, Nemetz D, Schafer U, Nilles M, Hort W, et al. Treatment of head and neck dermatitis with ciclopiroxolamine cream - results of a double-blind, placebo-controlled study. Skin Pharmacol Physiol 2006; 19: 153-158.
67. Svejgaard E, Larsen PO, Deleuran M, et al. Treatment of head and neck dermatitis comparing itraconazole 200 mg and 400 mg daily for 1 week with placebo. J Eur Acad Dermatol Venereol 2004; 18: 445-449.
68. Broberg A, Faergemann J. Topical antimycotic treatment of atopic dermatitis in the head/neck area. A double-blind randomised study. Acta Derm Venereol 1995; 75: 46-49.
69. Schwartz HJ, Ward GW. Onychomycosis, Trichophyton allergy and asthma - a causal relationship? Ann Allergy Asthma Immunol 1995; 74: 523-524.
70. Gumowski P, Lech B, Chaves I, Girard JP. Chronic asthma and rhinitis due to Candida albicans, Epidermophyton, and Trichophyton. Ann Allergy 1987; 59: 48-51.
71. Ward GW, Jr, Karlsson G, Rose G, Platts-Mills TA. Trichophyton asthma: sensitisation of bronchi and upper airways to dermatophyte antigen. Lancet 1989; 1: 859-862.
72. Schwartz HJ, Ward GW. Onychomycosis, Trichophyton allergy and asthma - a causal relationship? Ann Allergy Asthma Immunol 1995; 74: 523-524.
73. Ward GW, Jr,Woodfolk JA, Hayden ML, Jackson S, Platts-Mills TA. Treatment of late-onset asthma with fluconazole. J Allergy Clin. Immunol 1999; 104: 541-546.
74. Woodfolk JA. Allergy and dermatophytes. Clin Microbiol Rev 2005; 18: 30-43.
75. Crain EF, Weiss KB, Bijur PE, et al. An estimate of the prevalence of asthma and wheezing among inner-city children. Pediatrics 1994; 94: 356-362.
76. Grant EN, Daugherty SR, Moy JN, et al. Prevalence and burden of illness for asthma and related symptoms amongkindergartners in Chicago public schools. Ann Allergy Asthma Immunol 1999; 83: 113-120.
77. Newacheck PW, Halfon N. Access to ambulatory care services for economically disadvantaged children. Pediatrics 1986; 78: 813-819.
78. Belamarich PF, Luder E, Kattan M, Mitchell H, Islam S, Lynn H, et al. Do obese inner-city children with asthma have more symptoms than nonobese children with asthma? Pediatrics 2000; 106: 1436-1441.
79. Kunzli N, Kaiser R, Medina S, Studnicka M, Chanel O, Filliger P, et al. Public-health impact of outdoor and trafficrelated air pollution: a European assessment. Lancet 2000; 356: 795-801.
80. Eggleston PA, Rosenstreich D, Lynn H, Gergen P, Baker D, Kattan M, et al. Relationship of indoor allergen exposure to skin test sensitivity in inner-city children with asthma. J Allergy Clin Immunol 1998; 102: 563-570.
81. Merkus PJ, Van Toorenenbergen AW. Birds or zebras? Allergy 2002; 57: 566-569.
82. Curtis L, Lee BS, Cai D, Morozova I, Fan JL, Scheff P, et al. Pigeon allergens in indoor environments: a preliminary study. Allergy 2002; 57: 627-631.
83. Littman ML, Schneierson SS. Cryptococcus neoformans in pigeon excreta in New York City. Am J Hyg 1959; 69: 49-59.
84. Allende M, Pizzo PA, Horowitz M, Pass HI, Walsh TJ. Pulmonary cryptococcosis presenting as metastases in children with sarcomas. Pediatr Infect Dis J 1993; 12: 240-243.
85. Campbell GD. Primary pulmonary cryptococcosis. Am Rev Resp Dis 1966; 94: 236-243.
86. Salyer WR, Salyer DC, Baker RD. Primary complex of Cryptococcus and pulmonary lymph nodes. J Infect Dis 1974; 130: 74-77.
87. Garcia-Hermoso D, Janbon G, Dromer F. Epidemiological evidence for dormant Cryptococcus neoformans infection. J Clin Microbiol 1999; 37: 3204-3209.
88. Fleuridor R, Lyles RH, Pirofski L. Quantitative and qualitative differences in the serum antibody profiles of human immunodeficiency virus-infected persons with and without Cryptococcus neoformans meningitis. J Infect Dis 1999; 180: 1526-1535.
89. Saha DC, Goldman DL, Shao X, Casadevall A, Husain S, Limaye AP, et al. Serologic evidence for reactivation of cryptococcosis in soild-organ transplant recipients. Clin. Vaccine Immunol. 2007; 14: 1550-1554.
90. Kanj SS, Welty-Woolf K, Madden J, Tapson V, Baez MA, Davis RD, et al. Fungal Infections in lung and heart-lung transplant recipients. Medicine 1996; 75: 142-156.
91. Goldman DL, Khine H, Abadi J, Lindenberg DJ, Pirofski L, Niang R, et al. Serologic evidence for Cryptococcus neoformans infection in early childhood. Pediatrics 2001; 107: E66.
92. Davis J, Zheng WY, Glatman-Freedman A, Ng JA, Pagcatipunan MR, Lessin H, et al. Serologic evidence for regional differences in pediatric cryptococcal infection. Pediatr Infect Dis J 2007; 26: 549-551.
93. Chen GH, McDonald RA, Wells JC, et al. The gamma interferon receptor is required for the protective pulmonary inflammatory response to Cryptococcus neoformans. Infect Immun 2005; 73: 1788-1796.
94. Goldman DL, Davis J, Bommarito F, Shao X, Casadevall A. Enhanced allergic inflammation and airway responsiveness in rats with chronic Cryptococcus neoformans infection: potential role for fungal pulmonary infection in the pathogenesis of asthma. J Infect Dis 2006; 193: 1178-1186.
95. Abe K, Kadota J, Ishimatsu Y, et al. Th1-Th2 cytokine kinetics in the bronchoalveolar lavage fluid of mice infected with Cryptococcus neoformans of different virulences. Microbiol Immunol 2000; 44: 849-855.
96. Blackstock R, Buchanan KL, Adesina AM, Murphy JW. Differential regulation of immune responses by highly and weakly virulent Cryptococcus neoformans isolates. Infect Immun 1999; 67: 3601-3609.
97. Kawakami K, Qureshi MH, Koguchi Y, Nakajima K, Saito A. Differential effect of Cryptococcus neoformans on the production of IL-12p40 and IL-10 by murine macrophages stimulated with lipopolysaccharide and gamma interferon. FEMS Microbio Lett 1999; 175: 87-94.
98. Blackstock R, Buchanan KL, Adesina AM, Murphy JW. Differential regulation of immune responses by highly and weakly virulent Cryptococcus neoformans isolates. Infect Immun 1999; 67: 3601-3609.
99. Huffnagle GB, Chen G-H, Curtis JL, et al. Down-regulation of the afferent phase of T cell-mediated pulmonary inflammation and immunity by a high melanin-producing strain of Cryptococcus neoformans. J Immunol 1995; 155: 3507-3516.
100. Vecchiarelli A, Retini C, Pietrella D, Monari C, Tascini C, Beccari T, et al. Downregulation by cryptococcal polysaccharide of tumor necrosis factor alpha and interleukin-1beta secretion from human monocytes. Infec Immun 1995; 63: 2919-2923.
101. Vecchiarelli A, Retini C, Monari C, Bistoni F, Kozel TR. Purified capsular polysaccharide of Cryptococcus neoformans induces interleukin-10 secretion by human monocytes. Infect Immun 1996; 64: 2846-2849. (Pubitemid 26226860)
102. Almeida GM, Andrade RM, Bento CA. The capsular polysaccharides of Cryptococcus neoformans activate normal CD4(-) T cells in a dominant Th2 pattern. J Immunol 2001; 167: 5845-5851.
103. Reese TA, Liang HE, Tager AM, Luster AD, Van Rooijen N, Voehringer D, et al. Chitin induces accumulation in tissue of innate immune cells associated with allergy. Nature 2007; 447: 92-96.
104. Zhu Z, Zheng T, Homer RJ, Kim YK, Chen NY, Cohn L, et al. Acidic mammalian chitinase in asthmatic Th2 inflammation and IL-13 pathway activation. Science 2004; 304: 1678-1682.
105. Bierbaum S, Nickel R, Koch A, Lau S, Deichmann KA, Wahn U, et al. Polymorphisms and haplotypes of acid mammalian chitinase are associated with bronchial asthma. Am J Respir Crit Care Med 2005; 172: 1505-1509.
106. Chupp GL, Lee CG, Jarjour N, Shim YM, Holm CT, He S, et al. A chitinase-like protein in the lung and circulation of patients with severe asthma. N Engl J Med 2007; 357: 2016-2027.
107. Overdijk B, Van Steijn GJ, Odds FC. Chitinase levels in guinea pig blood are increased after systemic infection with Aspergillus fumigatus. Glycobiology 1996; 6: 627-634.
108. Vicencio AG, Narain S, Du Z, Zeng WY, Ritch J, Casadevall A, et al. Pulmonary cryptococcosis induces chitinase in the rat. Respir Res 2008; 9: 40.
109. Calderone RA (ed.). Candida and Candidiasis. Washington, DC: ASM Press, 2001: 472.
110. O'Garra A, Vieira P. Regulatory T cells and mechanisms of immune system control. Nature Medicine 2004; 10: 801-805.
111. Shevach EM. From vanilla to 28 flavors: multiple varieties of T regulatory cells. Immunity 2006; 25: 195-201.
112. Weiner HL. Oral tolerance: immune mechanisms and the generation of Th3-type TGF-beta-secreting regulatory cells. Microbes Infect 2001; 3: 947-954.
113. Perez-Machado MA, Ashwood P, Thomson MA, Latcham F, Sim R, Walker-Smith JA, et al. Reduced transforming growth factor-beta1-producing T cells in the duodenal mucosa of children with food allergy. Eur J Immunol 2003; 33: 2307-2315.
114. Frossard CP, Tropia L, Hauser C, Eigenmann PA. Lymphocytes in Peyer patches regulate clinical tolerance in a murine model of food allergy. J Allergy Clin Immunol 2004; 113: 958-964.
115. Tsuji NM, Mizumachi K, Kurisaki J. Interleukin-10-secreting Peyer's patch cells are responsible for active suppression in lowdose oral tolerance. Immunology 2001; 103: 458-464.
116. Chen Y, Kuchroo VK, Inobe J, Hafler DA, Weiner HL. Regulatory T cell clones induced by oral tolerance: suppression of autoimmune encephalomyelitis. Science 1994; 265: 1237-1240.
117. Iwasaki A, Kelsall BL. Freshly isolated Peyer's patch, but not spleen, dendritic cells produce interleukin 10 and induce the differentiation of T helper type 2 cells. J Exp Med 1999; 190: 229-239.
118. Zhang X, Izikson L, Liu L, Weiner HL. Activation of CD25(-)CD4(-) regulatory T cells by oral antigen administration. J Immunol 2001; 167: 4245-4253.
119. Bennett CL, Christie J, Ramsdell F, Brunkow ME, Ferguson PJ, Whitesell L, et al. The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3. Nat Genet 2001; 27: 20-21.
120. Powell BR, Buist NR, Stenzel P. An X-linked syndrome of diarrhea, polyendocrinopathy, and fatal infection in infancy. J Ped 1982; 100: 731-737.
121. Karlsson MR, Rugtveit J, Brandtzaeg P. Allergen-responsive CD4-CD25-regulatory T cells in children who have outgrown cow's milk allergy. J Exp Med 2004; 199: 1679-1688.
122. Montagnoli C, Bacci A, Bozza S, Gaziano R, Mosci P, Sharpe AH, et al. B7/CD28-dependent CD4-CD25- regulatory T cells are essential components of the memory-protective immunity to Candida albicans. J Immunol 2002; 169: 6298-6308
123. de Luca A, Montagnoli C, Zelante T, Bonifazi P, Bozza S, Moretti S, et al. Functional yet balanced reactivity to Candida albicans requires TRIF, MyD88, and IDO-dependent inhibition of Rorc. J Immunol 2007; 179: 5999-6008.
124. Bozza S, Fallarino F, Pitzurra L, Zelante T, Montagnoli C, Bellocchio S, et al. A crucial role for tryptophan catabolism at the host/Candida albicans interface. J Immunol 2005; 174: 2910-2918.
125. Van Ogtrop ML, Guiot HF, Mattie H, van Furth R. Modulation of the intestinal flora of mice by parenteral treatment with broad-spectrum cephalosporins. Antimicrob Agents Chemother 1991; 35: 976-982.
126. Sullivan A, Edlund C, Nord CE. Effect of antimicrobial agents on the ecological balance of human microflora. Lancet - Inf Dis 2001; 1: 101-114.
127. Giuliano M, Barza M, Jacobus NV, Gorbach SL. Effect of broad-spectrum parenteral antibiotics on composition of intestinal microflora of humans. Antimicrob Agents Chemother 1987; 31: 202-206. (Pubitemid 17011238)
128. Samonis G, Gikas A, Anaissie EJ, Vrenzos G, Maraki S, Tselentis Y, et al. Prospective evaluation of effects of broadspectrum antibiotics on gastrointestinal yeast colonization of humans. Antimicrob Agents Chemother 1993; 37: 51-53.
129. Orrhage K, Nord CE. Bifidobacteria and lactobacilli in human health. Drugs Exp Clin Res 2000; 26: 95-111.
130. Sjovall J, Huitfeldt B, Magni L, Nord CE. Effect of beta-lactam prodrugs on human intestinal microflora. Scand J Infect Dis Suppl 1986; 49: 73-84.
131. Lidbeck A, Nord CE. Lactobacilli and the normal human anaerobic microflora. Clin Infect Dis 1993; 16 (Suppl. 4): S181-S187.
132. Payne S, Gibson G, Wynne A, et al. In vitro studies on colonization resistance of the human gut microbiota to Candida albicans and the effects of tetracycline and Lactobacillus plantarum LPK. Curr Issues Intest Microbiol 2003; 4: 1-8.
133. Van Der Waaij D. The ecology of the human intestine and its consequences for overgrowth by pathogens such as Clostridium difficile. Annu Rev Microbiol 1989; 43: 69-87.
134. Guggenbichler JP, Kofler J, Allerberger F. The influence of thirdgeneration cephalosporins on the aerobic intestinal flora. Infection 1985; 13 (Suppl. 1): S137-S139.
135. Umetsu DT,McIntire JJ, Akbari O,Macaubas C, DeKruyff RH. Asthma: an epidemic of dysregulated immunity. Nat Immunol 2002; 3: 715-720.
136. Wills-Karp M, Santeliz J, Karp CL. The germless theory of allergic disease: revisiting the hygiene hypothesis. Nat Rev Immunol 2001; 1: 69-75.
137. Alm JS, Swartz J, Lilja G, Scheynius A, Pershagen G. Atopy in children of families with an anthroposophic lifestyle. Lancet 1999; 353: 1485-1488. (Pubitemid 29204367)
138. McKeever TM, et al. Early exposure to infections and antibiotics and the incidence of allergic disease: a birth cohort study with the West Midlands General Practice Research Database. J Allergy Clin Immunol 2002; 109: 43-50.
139. Wjst M, Hoelscher B, Frye C, et al. Early antibiotic treatment and later asthma. Eur J Med Res 2001; 6: 263-271.
140. Droste JH, Wieringa MH, Weyler JJ, et al. Does the use of antibiotics in early childhood increase the risk of asthma and allergic disease? Clin Exp Allergy 2000; 30: 1547-1553.
141. Bjorksten B, Naaber P, Sepp E, Mikelsaar M. The intestinal microflora in allergic Estonian and Swedish 2-year-old children. Clin Exp Allergy 1999; 29: 342-346.
142. Bottcher MF, Nordin EK, Sandin A, Midtvedt T, Bjorksten B. Microflora-associated characteristics in faeces from allergic and nonallergic infants. Clin Exp Allergy 2000; 30: 1590-1596.
143. Kalliomaki M, Kirjavainen P, Eerola E, et al. Distinct patterns of neonatal gut microflora in infants in whom atopy was and was not developing. J Allergy Clin Immunol 2001; 107: 129-134.
144. Kirjavainen PV, Apostolou E, Arvola T, et al. Characterizing the composition of intestinal microflora as a prospective treatment target in infant allergic disease. FEMS Immunol Med Microbiol 2001; 32: 1-7.
145. Bjorksten B, Sepp E, Julge K, Voor T, Mikelsaar M. Allergy development and the intestinal microflora during the first year of life. J Allergy Clin Immunol 2001; 108: 516-520. (Pubitemid 32978019)
146. Bandeira A, Mota-Santos T, Itohara S, Degermann S, Heusser C, Tonegawa S, et al. Localization of gamma/delta T cells to the intestinal epithelium is independent of normal microbial colonization. J Exp Med 1990; 172: 239-244.
147. Lefrancois L, Goodman T. In vivo modulation of cytolytic activity and Thy-1 expression in TCR-gamma delta- intraepithelial lymphocytes. Science 1989; 243: 1716-1718.
148. Yamanaka T, Helgeland L, Farstad IN, et al. Microbial colonization drives lymphocyte accumulation and differentiation in the follicle-associated epithelium of Peyer's patches. J Immunol 2003; 170: 816-822.
149. Cooper MD, Kincade PW, Bockman DE, Lawton AR. Origin, distribution and differentiation of IgA-producing cells. Adv Exp Med Biol 1974; 45: 13-22.
150. Bos NA, Cebra JJ, Kroese FG. B-1 cells and the intestinal microflora. Curr Top Microbiol Immunol 2000; 252: 211-220.
151. Umesaki Y, Setoyama H. Structure of the intestinal flora responsible for development of the gut immune system in a rodent model. Microbes Infect 2000; 2: 1343-1351.
152. Noverr MC, Falkowski NR, McDonald RA, Huffnagle GB. The development of allergic airway disease in mice following antibiotic therapy and fungal microbiota increase: role of host genetics, antigen and IL-13. Infect Immun 2005; 73: 30-38.
153. Noverr MC, Noggle RM, Toews GB, Huffnagle GB. Role of antibiotics and fungal microbiota in driving pulmonary allergic responses. Infect Immun 2004; 72: 4996-5003.
154. Yamaguchi N, Sugita R, Miki A, Takemura N, Kawabata J, Watanabe J, et al. Gastrointestinal Candida colonisation promotes sensitisation against food antigens by affecting the mucosal barrier in mice. Gut 2006; 55: 954-960.
155. Yamaguchi N, Sonoyama K, Kikuchi H, et al. Gastric colonization of Candida albicans differs in mice fed commercial and purified diets. J Nutr 2005; 135: 109-115.
156. Noverr MC, Phare SM, Toews GB, Coffey MJ, Huffnagle GB. Pathogenic yeasts Cryptococcus neoformans and Candida albicans produce immunomodulatory prostaglandins. Infect Immun 2001; 69: 2957-2963.
157. Tsitsigiannis DI, Bok JW, Andes D, et al. Aspergillus cyclooxygenase- like enzymes are associated with prostaglandin production and virulence. Infect Immun 2005; 73: 4548-4559.
158. Erb-Downward JR, Huffnagle GB. Cryptococcus neoformans produces authentic prostaglandin E2 without a cyclooxygenase. Eukaryot Cell 2007; 6: 346-350.
159. Erb-Downward JR, Noverr MC. Characterization of prostaglandin E2 production by Candida albicans. Infect Immun 2007; 75: 3498-3505.
160. Noverr MC, Erb-Downward JR, Huffnagle GB. Production of eicosanoids and other oxylipins by pathogenic eukaryotic microbes. Clin Microbiol Rev 2003; 16: 517-533.
161. Matsuoka T, et al. Prostaglandin D2 as a mediator of allergic asthma. Science 2000; 287: 2013-2017.
162. Peters-Golden M. Open mind, open airways: broadening the paradigm of prostaglandins and allergic airway inflammation. Am J Respir Crit Care Med 2002; 165: 1035-1036.
163. Angeli V, et al. Role of the parasite-derived prostaglandin D2 in the inhibition of epidermal Langerhans cell migration during schistosomiasis infection. J Exp Med 2001; 193: 1135-1147.
164. Herve M, et al. Pivotal roles of the parasite PGD2 synthase and of the host D prostanoid receptor 1 in schistosome immune evasion. Eur J Immunol 2003; 33: 2764-2772.
165. Fogelmark B, Thorn J, Rylander R. Inhalation of (1-3)-beta- D-glucan causes airway eosinophilia. Mediators Inflamm 2001; 10: 13-19.
166. Faergemann J. Atopic dermatitis and fungi. Clin Microbiol Rev 2002; 15: 545-563.
167. Lacour M, Zunder T, Huber R, Sander A, Daschner F, Frank U. The pathogenetic significance of intestinal Candida colonization - a systematic review from an interdisciplinary and environmental medical point of view. Int J Hyg Environ Health 2002; 205: 257-268.
168. Nikkels AF, Pierard GE. Framing the future of antifungals in atopic dermatitis. Dermatology 2003; 206: 398-400.
169. Garcia YH, Diez SG, Aizpun LT, Oliva NP. Antigliadin antibodies associated with chronic mucocutaneous candidiasis. Pediatr Dermatol 2002; 19: 415-418.
170. Nieuwenhuizen WF, Pieters RH, Knippels LM, Jansen MC, Koppelman SJ. Is Candida albicans a trigger in the onset of coeliac disease? Lancet 2003; 361: 2152-2154
171. Peyrin-Biroulet L, Standaert-Vitse A, Branche J, Chamaillard M. IBD serological panels: facts and perspectives. Inflamm Bowel Dis 2007; 13: 1561-1566.
172. Schaffer T, Muller S, Flogerzi B, et al. Anti-Saccharomyces cerevisiae mannan antibodies (ASCA) of Crohn's patients crossreact with mannan from other yeast strains, and murine ASCA IgM can be experimentally induced with Candida albicans. Inflamm Bowel Dis 2007; 13: 1339-1346.
173. Eaton K. Is there an allergic and fermentative gut condition, and does it relate to Candida? In: Brostoff J, Challacombe SJ (eds). Food Allergy and Intolerance. London: Saunders, 2002: 351-364.